Anti-TNF Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease

This cohort study uses 2 large administrative claims databases to examine the incidence of Parkinson disease among patients with inflammatory bowel disease and to assess whether exposure to antitumor necrosis factor therapy among these patients mitigates Parkinson disease risk.

Read the full article here

Related Articles